BIO3 RESEARCH Logo (USPTO, 03/15/2010)
USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark BIO3 RESEARCH was filed as Word and figurative mark on 03/15/2010 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 01/31/2012.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word and figurative mark |
| File reference | 77959249 |
| Register number | 4092757 |
| Application date | March 15, 2010 |
| Publication date | November 15, 2011 |
| Entry date | January 31, 2012 |
Trademark owner
Corso Venezia, 24
20121 Milan
IT
20121 Milan
IT
Trademark representatives
goods and services
5
Biological preparations for medical purposes for the treatment of cardiovascular, dermatological, oncological, ocular, renal and immune system related diseases and disorders; biological preparations for medical purposes for the treatment of anaemia and oxidative stress from haemodialysis and from whatever origin; biological preparations for medical purposes for the treatment of wounds, burns and bedsores, damaged skin and tissue; biological preparations for medical purposes for tissue and bone matrix regeneration, connective tissue repair, and cartilage repair; biological preparations for medical purposes for the treatment of diseases related to HMGB1 protein over-expression and HMGB1 biological properties; biological preparations for medical purposes for the treatment of restenosis and atherosclerosis; biological preparations for medical purposes for the treatment of psoriasis; pharmaceutical preparations and substances for the treatment of cardiovascular, dermatological, oncological, ocular, renal and immune system related diseases and disorders; pharmaceutical preparations for the treatment of oxidative stress from haemodialysis; pharmaceutical preparations and substances for the treatment of wounds, burns and bedsores, damaged skin and tissue; pharmaceutical preparations and substances for the tissue and bone matrix regeneration, connective tissues repair, cartilage repair; therapeutic pharmaceutical agents for the treatment of diseases related to HMGB1 protein over-expression and HMGB1 biological properties; pharmaceutical preparations and substances for the treatment of restenosis and atherosclerosis; pharmaceutical preparations for the treatment of psoriasis; biological preparations for medical purposes for cloning and their variant DNA recombinant
42
Scientific research in the biopharmaceutical field, namely, focused in the areas of cardiovascular disorders, such as restenosis, atherosclerosis and arterial stenosis, connective tissue and tissue regeneration such as wound healing, cartilage repair, bone matrix regeneration, burns and bedsores and renal and skin diseases; research in the oncological field; medical and scientific research, namely, conducting clinical trials and clinical studies
ID: 1377959249